The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.
about
Lymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersRecent insights in the pathogenesis of post-transplantation lymphoproliferative disordersInfection in Organ Transplantation.EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53Posttransplant Lymphoproliferative Disorder: Otolaryngological Manifestations and Management.Both high and low levels of cellular Epstein-Barr virus DNA in blood identify failure after hematologic stem cell transplantation in conjunction with acute GVHD and type of conditioning.EBV-Positive and EBV-Negative Posttransplant Diffuse Large B Cell Lymphomas Have Distinct Genomic and Transcriptomic Features.Mutational landscape of B-cell post-transplant lymphoproliferative disorders.Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.Posttransplant lymphoproliferative disorders in kidney transplant recipients: a retrospective cohort analysis over two decades in Hong Kong.Comprehensive review of post-organ transplant hematologic cancers.Post-transplant lymphoproliferative disorder: a heterogeneous conundrum.Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases.Shaping the Molecular Landscape of Posttransplantation Lymphoproliferative Disorders.Post-transplant lymphoproliferative disorder of the bladder in a lung transplant recipient.Impact of the posttransplant lymphoproliferative disorder subtype on survival.Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation.
P2860
Q26776151-781E1D16-0F76-4FB9-B50B-5A47516CE50CQ28075701-29E4A67B-C816-4649-B7D8-60A113189A10Q30238810-4A38C51E-16AE-4A54-AD4B-60590945435DQ33594139-E9B413DA-DD6C-4964-BB9C-085634419F2BQ38680172-A38B7ADC-9EAA-4831-BCE9-9B6DB7827C1BQ38877813-30407BAE-9E5E-4D1F-A0C7-E839232C726FQ40094003-C6AC4512-7B53-4057-A8D1-A69219F744E8Q40238236-83D6162C-88F5-4BCC-B583-FFB3D48CE45DQ42368054-5ADEDC0F-1708-4CB0-A84A-D6A44DAC0D89Q47148062-18EF4CAB-7651-465D-A7E3-96DB23FF888BQ47572480-E283AB14-D634-4F48-830C-FC0D76369B5AQ47611981-44FD4523-53BC-43F2-A916-835D923157B3Q47799831-C9326AD2-3363-4930-927D-6872DABC8A50Q50909795-BEA5A54C-D5DE-4337-B1A3-BE00F086E968Q51733100-8FB0F9BE-CA3E-4FD7-8A8B-31C3FF6B7BC2Q51734713-FCA6CDF0-D188-4142-9931-C86CE135FDC3Q53183825-29B1734F-EC46-47D1-A27F-D0C44F164732
P2860
The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Impact of EBV Status on Ch ...... Lymphoproliferative Disorder.
@en
type
label
The Impact of EBV Status on Ch ...... Lymphoproliferative Disorder.
@en
prefLabel
The Impact of EBV Status on Ch ...... Lymphoproliferative Disorder.
@en
P2093
P2860
P356
P1476
The Impact of EBV Status on Ch ...... Lymphoproliferative Disorder.
@en
P2093
D F Heitjan
D L Porter
E A Stadtmauer
M R Luskin
R H Vonderheide
P2860
P304
P356
10.1111/AJT.13324
P407
P577
2015-05-18T00:00:00Z